Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Oncoimmunology|February 6, 2014
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastomaVidyalakshmi Chandramohan, Darell D Bigner
Expert Review of Anticancer Therapy|June 9, 2006
Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncologyMichael W Graner, Darell D Bigner
Neuro-Oncology|August 2, 2005
Chaperone proteins and brain tumors: potential targets and possible therapeuticsMichael W Graner, Darell D Bigner
Expert Review of Anticancer Therapy|May 12, 2007
Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patientsDavid A Reardon, Michael R Zalutsky, Darell D Bigner
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 19, 2007
The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequencesMichael W Graner, R Ian Cumming, Darell D Bigner
Receptors & Clinical Investigation|March 14, 2017
EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced deliveryXuhui Bao, Ira Pastan, Darell D Bigner, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast displayXin Yu, Liang Qu, Darell D Bigner, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Cancer Research|December 10, 2009
Mutant metabolic enzymes are at the origin of gliomasHai Yan, Darell D Bigner, Victor Velculescu, et al.
Journal of Immunological Methods|December 28, 2016
Development and validation of a cell-based fluorescent method for measuring antibody affinityXin Yu, Charles N Pegram, Darell D Bigner, et al.
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Oncoimmunology|February 6, 2014
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastomaVidyalakshmi Chandramohan, Darell D Bigner
Expert Review of Anticancer Therapy|June 9, 2006
Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncologyMichael W Graner, Darell D Bigner
Neuro-Oncology|August 2, 2005
Chaperone proteins and brain tumors: potential targets and possible therapeuticsMichael W Graner, Darell D Bigner
Expert Review of Anticancer Therapy|May 12, 2007
Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patientsDavid A Reardon, Michael R Zalutsky, Darell D Bigner
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 19, 2007
The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequencesMichael W Graner, R Ian Cumming, Darell D Bigner
Receptors & Clinical Investigation|March 14, 2017
EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced deliveryXuhui Bao, Ira Pastan, Darell D Bigner, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast displayXin Yu, Liang Qu, Darell D Bigner, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Cancer Research|December 10, 2009
Mutant metabolic enzymes are at the origin of gliomasHai Yan, Darell D Bigner, Victor Velculescu, et al.
Journal of Immunological Methods|December 28, 2016
Development and validation of a cell-based fluorescent method for measuring antibody affinityXin Yu, Charles N Pegram, Darell D Bigner, et al.
Pageof 25